JamesJosephFoxMD

Cardiology • Sarasota, FL

Adult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology

Physician

Join to view full profile

Are you Dr. Fox?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 57 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
1540 S Tamiami Trl
Suite 401
Sarasota, FL 34239
Phone+1 941-917-0060

Fax+1 941-316-9216
Is this information wrong?

Summary

Dr. James Fox, MD is a cardiologist in Sarasota, Florida. He is currently licensed to practice medicine in Florida and New Jersey. He is affiliated with Sarasota Memorial Hospital - Sarasota and Venice Regional Bayfront Health.

Education & Training

Hackensack University Medical CenterFellowship, Cardiovascular Disease, 1989 - 1992
Hackensack University Medical CenterResidency, Internal Medicine, 1984 - 1987
Universidad de GuadalajaraClass of 1983

Certifications & Licensure

FL State Medical License 1992 - 2026
NJ State Medical License 1986 - 1993
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

Sarasota Magazine: Top Doctors Castle Connolly, 2007-2014
CMS Meaningful Use Stage 1 Certification SRS EHR, SRSsoft, 2013
Fellow (FACC) American College of Cardiology

Publications & Presentations

PubMed

Sequential SPECT and Optical Imaging of Experimental Models of Prostate Cancer with a Dual Modality Inhibitor of the Prostate-Specific Membrane Antigen.
> ;Angew Chem Int Ed Engl. 2011 Sep 19
Imaging CXCR4 Expression in Human Cancer Xenografts: Evaluation of Monocyclam 64Cu-AMD3465.
De Silva, R.A., Peyre, K., Pullambhatla, M., Fox, J.J., Pomper, M.G., Nimmagadda, S.> ;J Nucl Med. 2011 Jun
68Ga-labeled inhibitors of prostate-specific membrane antigen (PSMA) for imaging prostate cancer.
Banerjee, S.R., Pullambhatla, M., Byun, Y., Nimmagadda, S., Green, G., Fox, J.J., Horti, A., Mease, R.C., Pomper, M.G.> ;J Med Chem. 2010 Jul 22
Radiohalogenated prostate-specific membrane antigen (PSMA)-based ureas as imaging agents for prostate cancer.
Chen, Y., Foss, C.A., Byun, Y., Nimmagadda, S., Pullambhatla, M., Fox, J.J., Castanares, M., Lupold, S.E., Babich, J.W., Mease, R.C., Pomper, M.G.> ;J Med Chem. 2008-12-25
Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors.
Fu, D., Tanhehco, Y., Chen, J., Foss, C.A., Fox, J.J., Chong, J., Hobbs, R.F., Fukayama, M., Sgouros, G., Kowalski, J., Pomper, M.G., Ambinder, R.F.> ;Nat Med. 2008 Oct
An immunotolerant HER-2/neu transgenic mouse model of metastatic breast cancer.
Song, H., Shahverdi, K., Huso, D.L., Wang, Y., Fox, J.J., Hobbs, R.F., Gimi, B., Gabrielson, K.L., Pomper, M.G., Tsui, B.M., Bhujwalla, Z., Reilly, R.T., Sgouros, G.> ;Clin Cancer Res. 2008-10-01
Synthesis and evaluation of technetium-99m- and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA).
Banerjee, S.R., Foss, C.A., Castanares, M., Mease, R.C., Byun, Y., Fox, J.J., Hilton, J., Lupold, S.E., Kozikowski, A.P., Pomper, M.G.> ;J Med Chem. 2008 Aug 14
In vivo PET imaging of cardiac presynaptic sympathoneuronal mechanisms in the rat.
Tipre, D.N., Fox, J.J., Holt, D.P., Green, G., Yu, J., Pomper, M., Dannals, R.F., Bengel, F.M.> ;J Nucl Med. 2008 Jul
N-[N-[(S)-1,3-Dicarboxypropyl]carbamoyl]-4-[18F]fluorobenzyl-L-cysteine, [18F]DCFBC: a new imaging probe for prostate cancer.
Mease, R.C., Dusich, C.L., Foss, C.A., Ravert, H.T., Dannals, R.F., Seidel, J., Prideaux, A., Fox, J.J., Sgouros, G., Kozikowski, A.P., Pomper, M.G.> ;Clin Cancer Res. 2008 May 15
Virus-associated tumor imaging by induction of viral gene expression.
Fu, D., Tanhehco, Y.C., Chen, J., Foss, C.A., Fox, J.J., Lemas, V., Chong, J., Ambinder, R.F., Pomper, M.G.> ;Clin Cancer Res. 2007 Mar 1
Radiolabeled anti-claudin 4 and anti-prostate stem cell antigen: initial imaging in experimental models of pancreatic cancer.
Foss, C.A., Fox, J.J., Feldmann, G., Maitra, A., Iacobuzio-Donohue, C., Kern, S.E., Hruban, R., Pomper, M.G.> ;Mol Imaging. 2007-03-01
Inhibition of simian varicella virus infection of monkeys by 1-(2-deoxy-2- fluoro-1-beta-D-arabinofuranosyl)-5-ethyluracil (FEAU) and synergistic effects of combinatio...
Soike KF, Chou TC, Fox JJ, Watanabe KA, Gloff CA> ;Antiviral Res.. 1990-04-01
Inhibitory effects of 2'-fluorinated arabinosyl-pyrimidine nucleosides on woodchuck hepatitis virus replication in chronically infected woodchucks.
Fourel I, Hantz O, Watanabe KA, Jacquet C, Chomel B, Fox JJ, Trepo C> ;Antimicrob. Agents Chemother.. 1990-03-01
Incorporation and metabolism of 2'-fluoro-5-substituted arabinosyl pyrimidines and their selective inhibition of viral DNA synthesis in herpes simplex virus type 1 (HS...
Kong XB, Scheck AC, Price RW, Vidal PM, Fanucchi MP, Watanabe KA, Fox JJ, Chou TC> ;Antiviral Res.. 1988-12-01
Cell differentiation effects of 2'-fluoro-1-beta-D-arabinofuranosyl pyrimidines in HL-60 cells.
Kong XB, Andreeff M, Fanucchi MP, Fox JJ, Watanabe KA, Vidal P, Chou TC> ;Leuk. Res.. 1987-01-01
Kinetics and substrate specificity of human and canine cytidine deaminase.
Fanucchi MP, Watanabe KA, Fox JJ, Chou TC> ;Biochem. Pharmacol.. 1986-04-01
Biotransformation and elimination of [2-14C]-1-(2-deoxy-2'-fluoro-beta-D -arabinofuranosyl)-5-iodocytosine in immunosuppressed patients with herpesvirus infections.
Feinberg A, Leyland-Jones B, Fanucchi MP, Hancock C, Fox JJ, Watanabe KA, Vidal PM, Williams L, Young CW, Philips FS> ;Antimicrob. Agents Chemother.. 1985-05-01
Structures of metabolites isolated from urine of mice treated with the antiviral agent, 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5-methyluracil.
Feinberg A, Vidal PM, Fox JJ, Watanabe KA, Chun MW, Field FH, Bencsath A, Chait B, Philips FS> ;Drug Metab. Dispos.. 1984-01-01
Phase I evaluation of 2'-fluoro-5-iodo-1-beta-D-arabinofuranosylcytosine in immunosuppressed patients with herpesvirus infection.
Young CW, Schneider R, Leyland-Jones B, Armstrong D, Tan CT, Lopez C, Watanabe KA, Fox JJ, Philips FS> ;Cancer Res.. 1983-10-01
Quantitative autoradiographic mapping of herpes simplex virus encephalitis with a radiolabeled antiviral drug.
Saito Y, Price RW, Rottenberg DA, Fox JJ, Su TL, Watanabe KA, Philips FS> ;Science. 1982-09-17
Pharmacological disposition and metabolic fate of 2'-fluoro-5-iodo-1-beta-D-arabinofuranosylcytosine in mice and rats.
Chou TC, Feinberg A, Grant AJ, Vidal P, Reichman U, Watanabe KA, Fox JJ, Philips FS> ;Cancer Res.. 1981-09-01
Metabolism and effects of 5-(beta-D-ribofuranosyl)isocytosine in P815 cells.
Chou TC, Burchenal JH, Fox JJ, Watanabe KA, Chu CK, Philips FS> ;Cancer Res.. 1979-03-01
Diagnostic imaging of herpes simplex virus encephalitis using a radiolabeled antiviral drug: autoradiographic assessment in an animal model.
Saito, Y., Rubenstein, R., Price, R. W., Fox, J. J., Watanabe, K. A.> ;Ann Neurol. 1984 Jun
Distribution, metabolism, and excretion of 1-(2-fluoro-2-deoxy-beta-D- arabinofuranosyl)thymine and 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5- iodocytosine.
Philips, F. S., Feinberg, A., Chou, T. C., Vidal, P. M., Su, T. L., Watanabe, K. A., Fox, J. J.> ;Cancer Res. 1983 Aug
Phase I trial of 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-methyluracil (FMAU).
Fanucchi, M. P., Leyland-Jones, B., Young, C. W., Burchenal, J. H., Watanabe, K. A., Fox, J. J.> ;Cancer Treat Rep. 1985 Jan
Join now to see all

Professional Memberships

American College of Cardiology - ACC
Member

Hospital Affiliations

Sarasota Memorial Hospital - SarasotaSarasota, Florida
Venice Regional Bayfront HealthVenice, Florida